2026年5月16日 13:56 UTC / 路透社
FDA药品中心负责人在局长离职后被解雇
路透社报道
2026年5月16日 13:56 UTC 更新于2小时前
美国马里兰州怀特奥克市美国食品药品监督管理局（FDA）总部外的标识牌，2020年8月29日摄。路透社/安德鲁·凯利/档案照片 购买授权，打开新标签页
企业板块
美国食品药品监督管理局 关注
5月16日（路透社）——美国食品药品监督管理局药品中心代理负责人特蕾西·贝丝·赫格（Tracey Beth Hoeg）表示，她已被该机构解雇。
路透社此前率先报道称，赫格预计将于周五离职，而就在几天前，该局局长马蒂·马卡里（Marty Makary）已辞职。
通过《每日案卷》通讯将最新法律新闻直接发送到您的收件箱，开启您的清晨时光。在此注册。
赫格通过X平台的帖子宣布了自己的离职，她是一名流行病学家兼运动医学医生，在新冠疫情期间曾对新冠疫苗表示过质疑。
广告 · 滚动继续阅读
今年1月，她还牵头参与了美国儿童疫苗接种计划的改革工作，将推荐接种的疫苗剂次从17剂缩减至11剂。
赫格的离职正值卫生部门全面改组之际。近几个月来，白宫加强了对该部门的管控。
白宫已任命克里斯·克伦普（Chris Klomp）担任肯尼迪的副手，此后克伦普协助任命了一批更为传统的高级卫生职位候选人，例如美国疾病控制与预防中心主任和卫生局局长。
据两位消息人士透露，自马卡里周二辞职以来，克伦普一直在推动清除FDA内有争议的任命人员，并用更为传统的人选取而代之。
本报记者阿努沙·沙阿（Anusha Shah）班加罗尔报道，路易丝·埃文斯（Louise Heavens）编辑
我们的报道准则：汤森路透信托原则，打开新标签页
By Reuters
May 16, 2026 1:56 PM UTC Updated 2 hours ago
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights, opens new tab
Companies
U.S. Food and Drug Administration Follow
May 16 (Reuters) – The acting head of the U.S. Food and Drug Administration’s drug center, Tracey Beth Hoeg, said she had been fired from the agency.
Reuters first reported Hoeg was expected to leave the FDA on Friday, just days after Commissioner Marty Makary resigned.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Hoeg, who announced her departure via an X post, is an epidemiologist and sports physician who cast doubt on COVID vaccines during the pandemic.
Advertisement · Scroll to continue
She also helped lead the effort to overhaul the U.S. childhood vaccination schedule by reducing the number of recommended shots from 17 to 11 in January.
Hoeg’s departure comes amid a wider shake-up of the health department. The White House has exerted more control over the department in recent months.
The White House installed Chris Klomp as Kennedy’s No. 2, and Klomp has since helped bring in a slate of more conventional nominees for top health positions, such as director of the Centers for Disease Control and Prevention and Surgeon General.
Since Makary’s resignation on Tuesday, Klomp has been pushing to rid the FDA of controversial appointees and replace them with more traditional picks, according to two of the sources.
Reporting by Anusha Shah in Bengaluru, Editing by Louise Heavens
Our Standards: The Thomson Reuters Trust Principles., opens new tab
发表回复